Literature DB >> 12834668

Plasma homocysteine is elevated in patients with exfoliation syndrome.

Roberto M Vessani1, Robert Ritch, Jeffrey M Liebmann, Mark Jofe.   

Abstract

PURPOSE: To compare plasma homocysteine concentrations among patients with exfoliation syndrome, exfoliative glaucoma, normal-tension glaucoma, and normal control subjects without vascular or inflammatory ocular disease or glaucoma.
DESIGN: Cross-sectional study.
METHODS: We tested 25 patients with exfoliation syndrome, 50 with exfoliative glaucoma, 25 with normal-tension glaucoma, and 24 control subjects. Fasting plasma homocysteine concentrations were measured by fluorescence polarization immunoassay. Patients using vitamin supplements or medications known to alter serum homocysteine were excluded.
RESULTS: Homocysteine levels were higher in both exfoliatin groups compared with controls (exfoliation syndrome: P =.003; exfoliative glaucoma: P =.009); levels in normal-tension glaucoma were higher than but not significantly different from those in controls (P =.2). Hyperhomocysteinemia was present in 16 of 25 (64%) exfoliation syndrome patients, 28 of 50 (56%) exfoliative glaucoma patients, 13 of 25 (52%) normal-tension glaucoma patients, and 7 of 24 (29.2%) controls (P =.005). Multiple logistic regression analyses comparing exfoliation syndrome and exfoliative glaucoma patients with controls indicated that elevated plasma homocysteine concentration was a significant risk factor for exfoliation syndrome, in both those patients (odds ratios per 1.0 micromol/l increase in plasma homocysteine concentrations = 1.47; 95% confidence interval [CI] = 1.08-2.0) and in exfoliative glaucoma patients (odds ratio = 1.3; 95% CI = 1.07-1.6). Although exfoliative glaucoma and normal-tension glaucoma patients were not significantly different with respect to hyperhomocysteinemia, logistic regression modeling of exfoliative glaucoma vs normal-tension glaucoma patients showed that an increased homocysteine concentration was a significant risk factor for exfoliation syndrome in the presence of glaucoma (odds ratio per 1.0 micromol/l increase in homocysteine = 1.2, 95% CI = 1.0-1.4). These relationships were not affected by adjustment for potential confounding due to sex, history of hypertension, or other factors.
RESULTS: Elevated plasma homocysteine, a risk factor for cardiovascular disease, is more common in exfoliation syndrome and exfoliative glaucoma patients than healthy controls. Patients with exfoliation syndrome may benefit from measurement of homocysteine levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834668     DOI: 10.1016/s0002-9394(03)00077-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  42 in total

1.  Nailfold capillary morphology in exfoliation syndrome.

Authors:  C C Cousins; J H Kang; C Bovee; J Wang; S H Greenstein; A Turalba; L Q Shen; S Brauner; T Boumenna; S Blum; H Levkovitch-Verbin; R Ritch; J L Wiggs; P A Knepper; L R Pasquale
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Cerebrovascular blood flow velocities in pseudoexfoliation.

Authors:  Nurşen Yüksel; Yonca Anik; Aysun Kiliç; Vlevent Karabaş; Ali Demirci; Yusuf Cağlar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-13       Impact factor: 3.117

3.  Exfoliation and carotid stiffness.

Authors:  M Irkec
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

Review 4.  [PEX syndrome. Clinical diagnosis and systemic manifestations].

Authors:  E Scharfenberg; U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

5.  Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome.

Authors:  K Türkyılmaz; V Öner; A Kırbas; M S Sevim; B Sekeryapan; G Özgür; M Durmus
Journal:  Eye (Lond)       Date:  2013-05-10       Impact factor: 3.775

6.  Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma.

Authors:  J B Roedl; S Bleich; U Reulbach; N von Ahsen; U Schlötzer-Schrehardt; R Rejdak; G O H Naumann; F E Kruse; J Kornhuber; A G M Jünemann
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

7.  Retinal Ganglion Cell Loss and Mild Vasculopathy in Methylene Tetrahydrofolate Reductase (Mthfr)-Deficient Mice: A Model of Mild Hyperhomocysteinemia.

Authors:  Shanu Markand; Alan Saul; Penny Roon; Puttur Prasad; Pamela Martin; Rima Rozen; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

8.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

9.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

10.  Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma.

Authors:  Burak Turgut; Murat Kaya; Sermal Arslan; Tamer Demir; Mete Güler; Mehmet Kaan Kaya
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.